Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GYNET: NP137 Combinations in Gynecologic Cancers
NCT04652076Phase 2Active, not recruiting
- Sponsor
- NETRIS Pharma
- Start
- Dec 2020
- Primary completion
- Oct 2025
- Modality
- Prophylactic Vaccines, IgG Antibodies, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of np137 in endometrial carcinoma, cervical carcinoma, sponsored by NETRIS Pharma. Started Dec 2020; status: active, not recruiting.
02
Drugs
np137
03
Conditions
endometrial carcinomacervical carcinoma
Beyond the preview
Go deeper on NCT04652076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04652076.